ATP and arterial calcification (Q38080569)

28 August 2017

title

ATP and arterial calcification (English)

1 reference

28 August 2017

Richard S Fish

1

1 reference

28 August 2017

Enriko Klootwijk

2

1 reference

28 August 2017

Frederick W K Tam

3

1 reference

28 August 2017

Robert Kleta

4

1 reference

28 August 2017

David C Wheeler

5

1 reference

28 August 2017

Robert J Unwin

6

1 reference

28 August 2017

Jill Norman

7

1 reference

28 August 2017

language of work or name

1 reference

10 February 2013

1 reference

European Journal of Clinical Investigation

28 August 2017

published in

1 reference

28 August 2017

volume

43

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

405-412

1 reference

Coronary artery calcification and mortality in diabetic patients with proteinuria

28 August 2017

cites work

1 reference

Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease

21 January 2018

1 reference

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

21 January 2018

1 reference

Vascular calcification: the killer of patients with chronic kidney disease

21 January 2018

1 reference

Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.

21 January 2018

1 reference

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

21 January 2018

1 reference

Role of calcium-phosphate deposition in vascular smooth muscle cell calcification

21 January 2018

1 reference

Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization.

21 January 2018

1 reference

Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition

21 January 2018

1 reference

Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin

21 January 2018

1 reference

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

21 January 2018

1 reference

21 January 2018

Purinergic signalling

1 reference

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

P2 receptor expression profiles in human vascular smooth muscle and endothelial cells

21 January 2018

1 reference

Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium

21 January 2018

1 reference

P2 receptors in cardiovascular regulation and disease

21 January 2018

1 reference

The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y2-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation

21 January 2018

1 reference

Cellular function and molecular structure of ecto-nucleotidases.

21 January 2018

1 reference

New insights into NPP1 function: lessons from clinical and animal studies

21 January 2018

1 reference

Release of endogenous ATP during sympathetic nerve stimulation.

21 January 2018

1 reference

ATP-stimulated release of ATP by human endothelial cells

21 January 2018

1 reference

Mechanisms of ATP release and signalling in the blood vessel wall

21 January 2018

1 reference

Inhibition of aortic calcification by means of pyrophosphate and polyphosphates

21 January 2018

1 reference

The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates

21 January 2018

1 reference

Treatment with pyrophosphate inhibits uremic vascular calcification

21 January 2018

1 reference

Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.

21 January 2018

1 reference

Plasma pyrophosphate and vascular calcification in chronic kidney disease

21 January 2018

1 reference

Reduced plasma pyrophosphate levels in hemodialysis patients

21 January 2018

1 reference

Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification

21 January 2018

1 reference

Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy

21 January 2018

1 reference

Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene

21 January 2018

1 reference

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

21 January 2018

1 reference

Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure

21 January 2018

1 reference

Arthritis and ankylosis in twy mice with hereditary multiple osteochondral lesions: with special reference to calcium deposition

21 January 2018

1 reference

Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine

21 January 2018

1 reference

Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice

21 January 2018

1 reference

The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells

21 January 2018

1 reference

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

21 January 2018

1 reference

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.

21 January 2018

1 reference

Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia

21 January 2018

1 reference

Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification

21 January 2018

1 reference

ATP acts as a survival signal and prevents the mineralization of aortic valve.

21 January 2018

1 reference

Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats.

21 January 2018

1 reference

Role of the mouse ank gene in control of tissue calcification and arthritis

21 January 2018

1 reference

Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia

21 January 2018

1 reference

Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH

21 January 2018

1 reference

Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle

21 January 2018

1 reference

Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone

21 January 2018

1 reference

Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression

21 January 2018

1 reference

21 January 2018

1 reference

Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone

21 January 2018

1 reference

Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia

21 January 2018

1 reference

Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification

21 January 2018

1 reference

Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification

21 January 2018

1 reference

NT5E mutations and arterial calcifications

21 January 2018

1 reference

Role of CD73 and extracellular adenosine in disease : Presented by Maria P. Abbracchio

21 January 2018

1 reference

The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

21 January 2018

1 reference

Ectonucleotidases of CD39 Family Modulate Vascular Inflammation and Thrombosis in Transplantation

21 January 2018

1 reference

The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation

21 January 2018

1 reference

NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

21 January 2018

1 reference

P2Y purinoceptors as potential emerging therapeutical target in vascular disease.

21 January 2018

1 reference

Phenotype Changes of the Vascular Smooth Muscle Cell Regulate P2 Receptor Expression as Measured by Quantitative RT-PCR

21 January 2018

1 reference

Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate

21 January 2018

1 reference

Purinergic signalling and bone remodelling.

21 January 2018

1 reference

Expression, signaling, and function of P2X7 receptors in bone.

21 January 2018

1 reference

Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12055

1 reference

28 August 2017

1 reference